Uniklinik RWTH Aachen is the first hospital to implement SphingoTec's innovative biomarkers
E-Mail Uniklinik RWTH Aachen is the first hospital to implement SphingoTec's innovative biomarkers in clinical routine with the aim of making intensive care diagnostics more precise The biomarkers for the real-time assessment of kidney function (penKid®) and endothelial function (bio-ADM®) are pioneering new diagnostic pathways in critical care settings Following a positive initial clinical evaluation of penKid® and bio-ADM®, the University Hospital RWTH Aachen has transferred the innovative diagnostic tools into clinical routine The novel biomarkers enable a better diagnosis and monit...
Source: eurekalert.org